Cedazuridine
Back to searchMolecule Structure
Scientific Name
Cedazuridine
Description of the Drug
Cedazuridine is a cytidine deaminase inhibitor coadministered with the hypomethylating agent decitabine for the treatment of variable forms of myelodysplastic syndrome (MDS).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB15694
http://www.drugbank.ca/drugs/DB15694
Brand Name(s)
Not Available
Company Owner(s)
Otsuka Pharmaceutical Co Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cytidine deaminase | SINGLE PROTEIN | INHIBITOR | CHEMBL4502 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL172256 |
| Human Metabolome Database | HMDB0304872 |
| DrugBank | DB15694 |
| PubChem: Thomson Pharma | 58101758 |
| PubChem | 25267009 |
| Nikkaji | J3.333.921F |
| BindingDB | 50007029 |
| DrugCentral | 5402 |
| Guide to Pharmacology | 11101 |
| rxnorm | CEDAZURIDINE |
| ZINC | ZINC000043205136 |
